
cbdMD YCBD
$ 0.44
0.09%
Quarterly report 2024-Q4
added 02-13-2025
Country |
![]() |
IPO year |
2017 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE AMERICAN |
CEO |
Mr. Martin A. Sumichrast |
Employees in the company |
182 |
Shares |
4.31 M |
Market Cap[1] |
$ 1.9 M |
EBITDA (LTM) |
$ -67.4 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.